CognitiveInvestigational

ACTH (4-10) Analogs

Intranasal, Subcutaneous injection

Overview

ACTH (4-10) analogs are synthetic peptides derived from the 4 to 10 amino acid sequence of adrenocorticotropic hormone, engineered to preserve neurotrophic and cognitive-enhancing properties while eliminating steroidogenic activity. These fragments are thought to influence attention, memory consolidation, and synaptic plasticity through melanocortin receptor interactions and modulation of neurotransmitter systems.

Mechanism of Action

They represent a class of nootropic peptides explored since the 1970s..

Research Summary & Key Findings

Early clinical studies in the 1970s and 1980s, published in psychopharmacology journals, reported improvements in attention and memory in healthy volunteers and patients with cognitive impairment. Subsequent research has been limited, and no ACTH fragment analogs have achieved regulatory approval for cognitive indications. Interest has been renewed in recent years for potential applications in ADHD and age-related cognitive decline.

Clinical Status

Investigational

ACTH (4-10) Analogs is in the investigational stage. While preclinical and early-phase data exist, it has not received regulatory approval for clinical use in the United States.

Administration Routes

IntranasalSubcutaneous injection

Related Peptides in Cognitive

Find a Provider

Find a verified provider who offers ACTH (4-10) Analogs therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply ACTH (4-10) Analogs.

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.